Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brazil launches nationwide effort to curb superbugs in hospitals

NCT ID NCT07514884

Knowledge-focused Sponsor: Hospital Alemão Oswaldo Cruz Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study helps 54 public hospitals in Brazil set up programs to use antibiotics more wisely. The goal is to fight antibiotic resistance, which makes infections harder to treat. Hospitals get training, support, and tools to improve their antibiotic practices. The study measures whether these programs work and if they save money.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

54 people

The number who actually took part.

Started

Mar 2025

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Public hospitals within the Brazilian Unified Health System (SUS) * Presence of an established Hospital Infection Prevention and Control (IPC) committee * Hospitals without an ASP or with an ASP classified as inadequate or basic, according to a standardized ASP assessment tool * Availability of at least one infectious diseases physician (or physician with expertise in infectious diseases) or a clinical pharmacist with expertise in infectious diseases * Presence of at least one adult intensive care unit (ICU), including medical, surgical, or coronary ICU * Institutional agreement and commitment from hospital leadership to participate in the study Exclusion Criteria: * Hospitals without formal authorization or agreement from institutional leadership to participate in the study * Hospitals with adult ICUs currently involved in other antimicrobial stewardship or infection-related intervention studies that could interfere with the outcomes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Antimicrobial stewardship program are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Antimicrobial stewardship program Resistance bacterial

Contacts and locations

Locations

  • Hospital Alemão Oswaldo Cruz

    São Paulo, São Paulo, 01323-020, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.